Skip to main content
. Author manuscript; available in PMC: 2021 Oct 3.
Published in final edited form as: Breast Cancer Res Treat. 2021 May 10;188(3):615–630. doi: 10.1007/s10549-021-06239-y

Table 3.

Spearman’s rho correlation coefficients of the treatment prediction variables

ER HbT %Hb_EOC1 %HbT_EOC2 %HbT_EOC3 US %US_EOC1 %US_EOC2 %US_EOC3

HER2 −0.293 0.263 − 0.052 − 0.114 − 0.386 0.118 − 0.404 − 0.241 − 0.130
ER 0.171 − 0.129 − 0.210 − 0.196 − 0.191 − 0.164 − 0.222 − 0.269
TN 0.000 − 0.154 − 0.194 − 0.131 − 0.305 0.099 0.016 − 0.135
HbT − 0.449 − 0.582 − 0.463 − 0.015 − 0.167 − 0.180 0.234
%HbT_EOC1 0.701 * 0.641 0.151 − 0.076 0.037 0.104
%HbT_EOC2 0.644 − 0.039 0.192 0.142 0.239
%HbT_EOC3 0.202 0.282 0.220 0.399
US − 0.111 − 0.178 − 0.060
%US_EOC1 0.792 0.641
%US_EOC2 0.875
%US EOC3

Data were from this study of total 38 patients

*

The high correlation coefficients occur between %HbT_EOC1, %HbT_EOC2 and %HbT_EOC3, and between %US_EOC1, %US_EOC2, and %US_EOC3